Maven Securities
ISEE

Maven Securities’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Maven Securities’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-309,100
Closed -$12.2M – 1257
2023
Q2 		$12.2M Buy
+309,100
New +$10.9M 0.18% 71

Maven Securities's ISEE Position: Q3 2023 in Review

Maven Securities sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 124,278 shares — an estimated $4.89M sold.

Maven Securities first reported a position in ISEE in Q2 2020 and held it in 3 quarters. The position peaked at $4.89M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Maven Securities reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Maven Securities sold 124,278 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $4.89M.
  • Maven Securities first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Maven Securities's IVERIC bio, Inc. Common Stock position peaked at $4.89M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Maven Securities's 13F filing for Q3 2023, filed 13 Nov 2023.